NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Inhibition of human immunodeficiency virus gene amplification by heparin.

Author(s): Holodniy M, Kim S, Katzenstein D, Konrad M, Groves E, Merigan TC

Publication: J Clin Microbiol, 1991, Vol. 29, Page 676-9

PubMed ID: 1909709 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effect of anticoagulant type on the amplification of Human immunodeficiency virus (HIV) DNA and RNA from whole blood, plasma, serum and peripheral blood mononuclear cells (PBMC).

Conclusion of Paper

Less amplification of DNA from whole blood and DNA and RNA from PBMC and plasma was observed when blood was collected into sodium heparin then when whole blood, PBMC, plasma or serum were collected in acid-citrate-dextrose (ACD), EDTA, potassium oxalate or without any anticoagulants. However, this effect could be reversed by incubation of the extracted DNA with heparinase.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effect of anticoagulant type on the amplification of HIV DNA and RNA from whole blood, plasma, serum and PBMC. Blood was obtained from 5 HIV positive patients and 3 HIV negative patients. HIV infected U1 cells were added to some blood specimens obtained from HIV negative patients. RNA was extracted using guanadinium thiocyanate-phenol-chloroform, and DNA was extracted using phenol-chloroform.

    Summary of Findings:

    Less amplification of DNA from whole blood and DNA and RNA from PBMC and plasma was observed when blood was collected into sodium heparin then when whole blood, PBMC, plasma or serum were collected in ACD, EDTA, potassium oxalate or without anticoagulants. However, this effect could be reversed by incubation of the extracted DNA with heparinase. Further, the authors show that the addition of ≥0.5 units/mL of heparin directly to the PCR reaction inhibited amplification of placental DNA, but that this effect was partially attenuated by the addition of 10-fold more Taq polymerase to the reaction or by incubation with heparinase.

     

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Not specified
    • AIDS/HIV-related
    Platform:
    AnalyteTechnology Platform
    RNA RT-PCR
    DNA PCR
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Blood and blood products Plasma
    Serum
    Whole blood
    Peripheral blood mononuclear cells
    RT-PCR Specific Targeted nucleic acid HIV gag
    Biospecimen Acquisition Anticoagulant Acid-citrate-dextrose
    Sodium heparin
    Sodium EDTA
    Potassium oxalate
    None
    PCR Specific Reaction solution Heparinase
    No heparinase
    PCR Specific Targeted nucleic acid HIV gag
    Analyte Extraction and Purification Analyte purification Heparinase
    No heparinase
    PCR Specific Nucleic acid amplification 1 x Taq polymerase
    10 x Taq polymerase

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...